Tag Archives: Merck

The European Commission said that between 60% and 80% of the EU population was estimated to have been infected with COVID-19, as the bloc enters a post-emergency phase in which mass reporting of cases was no longer necessary. In preparing for this less acute phase, European Union governments should ramp …

U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections. The Food and Drug Administration authorization comes one day after the agency cleared a competing drug from Pfizer. That pill is likely to become the first-choice treatment …

Pfizer said Tuesday that its experimental COVID-19 pill appears effective against the omicron variant. The company also said full results of its 2,250-person study confirmed the pill’s promising early results against the virus: The drug reduced combined hospitalizations and deaths by about 89 percent among high-risk adults when taken shortly …

Pfizer Inc said on Thursday it had signed a $5.29 billion deal with the US government to deliver 10 million courses of its experimental COVID-19 antiviral drug, as the country rushes to secure promising oral treatments for the disease. The deal is rough twice the size of the contract the …

A World Health Organization-led program to ensure poorer countries get fair access to COVID-19 vaccines, tests and treatments aims to secure antiviral drugs for patients with mild symptoms for as little as $10 per course, a draft document seen by Reuters says. Merck & Co’s experimental pill molnupiravir is likely …

The plan to roll out Merck & Co’s promising antiviral pill to treat COVID-19 risks repeating the inequities of vaccine distribution, potentially leaving the nations with the greatest need once again at the back of the line, international health groups say. For example, only about 5% of Africa’s population is …

The World Health Organization is awaiting full clinical data on the antiviral pill made by Merck & Co Inc to treat mild-to-moderate COVID-19 patients, a WHO spokesperson said on Tuesday, a day after the company said it had applied for US emergency use authorization. WHO spokesperson Christian Lindmeier, asked at …

Merck & Co Inc said on Monday it has applied for emergency use authorization in the US for its oral drug to treat mild-to-moderate patients of COVID-19. The treatment, molnupiravir, has been developed with Ridgeback Biotherapeutics. If authorized, it would be the first oral antiviral medication. Data released last week …

Positive clinical trial results for Merck & Co’s (MRK.N) experimental antiviral COVID-19 pill reverberated through the healthcare sector on Friday, sending the drugmaker’s stock price soaring while denting high-flying shares of vaccine companies and makers of other coronavirus therapies. Merck shares jumped as much as 12.3% and hit their highest …

Biden administration officials say a new pill that could provide an easier, effective way to treat COVID 19 is good news while adding vaccination remains the key to controlling the pandemic. Officials at drug maker Merck say they’ll soon seek regulatory approval for the experimental pill, which reduced hospitalizations and …